Title
Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context
Date Issued
01 July 2008
Access level
open access
Resource Type
journal article
Author(s)
Soriano E.R.
Galarza-Maldonado C.
Cardiel M.H.
Pons-Estel B.A.
Massardo L.
Caballero-Uribe C.V.
Achurra-Castillo A.F.
Barile-Fabris L.A.
Díaz-Coto J.F.
Esteva-Spinetti M.H.
Guibert-Toledano M.
Palazuelos I.F.
Keiserman M.W.
Lomonte A.V.
Mota L.M.H.
Pineda Villaseñor C.
Publisher(s)
Oxford University Press
Start page
1097
End page
1099
Volume
47
Issue
7
Language
English
OCDE Knowledge area
Reumatología
Subjects
Scopus EID
2-s2.0-45749112561
PubMed ID
Source
Rheumatology
ISSN of the container
14620324
Sponsor(s)
Disclosure statement: E.R.S. has received grants from Abbott and support to attend ACR from Wyeth. M.H.C. has conducted clinical trials with rituximab as a principal investigator. L.M.H.M. has been a co-investigator in rituximab clinical trials for Roche and has received financial support for Medical Congress from Roche. C.G.-M. has been a principle investigator in biologic products clinical trials for Roche and Abbott. He has also received honoraria as an Advisory Board member for Wyeth. All other authors have declared no conflicts of interest.
Funding: The conceptualization of this consensus paper was made possible by an unrestricted grant from Roche.
Sources of information:
Directorio de Producción Científica
Scopus